What is the impact of biologic therapies on common co-morbidities in patients with rheumatoid arthritis?

por Humphreys, Jenny, Hyrich, Kimme, Symmons, Deborah
Publicado 2016

Prediction of infection risk in rheumatoid arthritis patients treated with biologics: are we any closer to risk stratification?

por Jani, Meghna, Barton, Anne, Hyrich, Kimme
Publicado 2019

Rheumatic disease and COVID-19: epidemiology and outcomes

por Hyrich, Kimme L., Machado, Pedro M.
Publicado 2020

Incidence and prevalence of juvenile idiopathic arthritis in the United Kingdom, 2000–2018: results from the Clinical Practice Research Datalink

por Costello, Ruth, McDonagh, Janet, Hyrich, Kimme L, Humphreys, Jenny H
Publicado 2021

Changes in disease characteristics and response rates among patients in the United Kingdom starting anti-tumour necrosis factor therapy for rheumatoid arthritis between 2001 and 20...

por Hyrich, Kimme L., Watson, Kath D., Lunt, Mark, Symmons, Deborah P. M.
Publicado 2011

Demyelinating Events Following Initiation of Anti-TNFα Therapy in the British Society for Rheumatology Biologics Registry in Rheumatoid Arthritis

por Taylor, Thomas R.P., Galloway, James, Davies, Rebecca, Hyrich, Kimme, Dobson, Ruth
Publicado 2021

OA35 Continuing specialist care into adulthood in young people with juvenile idiopathic arthritis: a retrospective cohort study using electronic health records in England

por Costello, Ruth, Kearsley-Fleet, Lianne, McDonagh, Janet, Hyrich, Kimme, Humphreys, Jenny
Publicado 2022

Factors associated with improvement in disease activity following initiation of etanercept in children and young people with Juvenile Idiopathic Arthritis: results from the British...

por Kearsley-Fleet, Lianne, Davies, Rebecca, Lunt, Mark, Southwood, Taunton R., Hyrich, Kimme L.
Publicado 2016

Medically Significant Infections Are Increased in Patients With Juvenile Idiopathic Arthritis Treated With Etanercept: Results From the British Society for Paediatric and Adolescen...

por Davies, Rebecca, Southwood, Taunton R., Kearsley‐Fleet, Lianne, Lunt, Mark, Hyrich, Kimme L.
Publicado 2015

Harnessing repeated measurements of predictor variables for clinical risk prediction: a review of existing methods

por Bull, Lucy M., Lunt, Mark, Martin, Glen P., Hyrich, Kimme, Sergeant, Jamie C.
Publicado 2020

P57 What are the outcomes of persistent oligoarthritis? A systematic review plan

por Smith, Andrew, Swindells-Macleod, Caledonia, Kearsley-Fleet, Lianne, Hyrich, Kimme, Shoop-Worrall, Stephanie
Publicado 2022

Rates and predictors of methotrexate-related adverse events in patients with early rheumatoid arthritis: results from a nationwide UK study

por Sherbini, Ahmad A, Gwinnutt, James M, Hyrich, Kimme L, Verstappen, Suzanne M M
Publicado 2022

Effectiveness of sequential biologic and targeted disease modifying anti-rheumatic drugs for rheumatoid arthritis

por Zhao, Sizheng Steven, Kearsley-Fleet, Lianne, Bosworth, Ailsa, Watson, Kath, Hyrich, Kimme L
Publicado 2022

Development of a sensitive biochemical assay for the detection of tofacitinib adherence

por Church, Stephanie, Hyrich, Kimme L., Ogungbenro, Kayode, Unwin, Richard D., Barton, Anne, Bluett, James
Publicado 2023

Benefit of anti-TNF therapy in rheumatoid arthritis patients with moderate disease activity

por Hyrich, Kimme L., Deighton, Chris, Watson, Kath D., Symmons, Deborah P. M., Lunt, Mark
Publicado 2009

Predictors, demographics and frequency of sustained remission and low disease activity in anti-tumour necrosis factor–treated rheumatoid arthritis patients

por Hamann, Philip D H, Pauling, John D, McHugh, Neil, Shaddick, Gavin, Hyrich, Kimme
Publicado 2019

Early response to anti-TNF predicts long-term outcomes including sustained remission: an analysis of the BSRBR-RA

por Hamann, Philip D H, Pauling, John D, McHugh, Neil, Hyrich, Kimme, Shaddick, Gavin
Publicado 2020

Long-term outcomes of patients who rate symptoms of rheumatoid arthritis as ‘satisfactory’

por Gwinnutt, James M, Hyrich, Kimme L, Lunt, Mark, Barton, Anne, Verstappen, Suzanne M M
Publicado 2020

Towards molecular-pathology informed clinical trials in childhood arthritis to achieve precision medicine in juvenile idiopathic arthritis

por Wedderburn, Lucy R, Ramanan, Athimalaipet V, Croft, Adam P, Hyrich, Kimme L, Dick, Andrew D
Publicado 2023

No Evidence of Association Between Anti–Tumor Necrosis Factor Treatment and Mortality in Patients With Rheumatoid Arthritis: Results From the British Society for Rheumatology Biolo...

por Lunt, Mark, Watson, Kath D, Dixon, William G, Symmons, Deborah P M, Hyrich, Kimme L
Publicado 2010